Eoneren/E+ via Getty Images Edwards Lifesciences In this analysis of Edwards Lifesciences Corp. (NYSE:EW), we looked into the growth potential of the Transcatheter Aortic Valve Replacement (TAVR) segment as it is the company’s main product accounting for 65.41% of revenues in 2021. Furthermore, we also analyzed SG&A as a percentage of revenue as the average […]